222 related articles for article (PubMed ID: 26918941)
1. microRNA-206 impairs c-Myc-driven cancer in a synthetic lethal manner by directly inhibiting MAP3K13.
Han H; Chen Y; Cheng L; Prochownik EV; Li Y
Oncotarget; 2016 Mar; 7(13):16409-19. PubMed ID: 26918941
[TBL] [Abstract][Full Text] [Related]
2. ANXA1 inhibits miRNA-196a in a negative feedback loop through NF-kB and c-Myc to reduce breast cancer proliferation.
Yuan Y; Anbalagan D; Lee LH; Samy RP; Shanmugam MK; Kumar AP; Sethi G; Lobie PE; Lim LH
Oncotarget; 2016 May; 7(19):27007-20. PubMed ID: 27105503
[TBL] [Abstract][Full Text] [Related]
3. c-MYC-regulated miR-23a/24-2/27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2.
Li X; Liu X; Xu W; Zhou P; Gao P; Jiang S; Lobie PE; Zhu T
J Biol Chem; 2013 Jun; 288(25):18121-33. PubMed ID: 23649631
[TBL] [Abstract][Full Text] [Related]
4. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
[TBL] [Abstract][Full Text] [Related]
5. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.
Xiong J; Du Q; Liang Z
Oncogene; 2010 Sep; 29(35):4980-8. PubMed ID: 20562918
[TBL] [Abstract][Full Text] [Related]
6. ROCK has a crucial role in regulating prostate tumor growth through interaction with c-Myc.
Zhang C; Zhang S; Zhang Z; He J; Xu Y; Liu S
Oncogene; 2014 Dec; 33(49):5582-91. PubMed ID: 24317511
[TBL] [Abstract][Full Text] [Related]
7. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
[TBL] [Abstract][Full Text] [Related]
8. A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.
Kessler JD; Kahle KT; Sun T; Meerbrey KL; Schlabach MR; Schmitt EM; Skinner SO; Xu Q; Li MZ; Hartman ZC; Rao M; Yu P; Dominguez-Vidana R; Liang AC; Solimini NL; Bernardi RJ; Yu B; Hsu T; Golding I; Luo J; Osborne CK; Creighton CJ; Hilsenbeck SG; Schiff R; Shaw CA; Elledge SJ; Westbrook TF
Science; 2012 Jan; 335(6066):348-53. PubMed ID: 22157079
[TBL] [Abstract][Full Text] [Related]
9. miR-181d and c-myc-mediated inhibition of CRY2 and FBXL3 reprograms metabolism in colorectal cancer.
Guo X; Zhu Y; Hong X; Zhang M; Qiu X; Wang Z; Qi Z; Hong X
Cell Death Dis; 2017 Jul; 8(7):e2958. PubMed ID: 28749470
[TBL] [Abstract][Full Text] [Related]
10. Identification of synthetic lethality of PRKDC in MYC-dependent human cancers by pooled shRNA screening.
Zhou Z; Patel M; Ng N; Hsieh MH; Orth AP; Walker JR; Batalov S; Harris JL; Liu J
BMC Cancer; 2014 Dec; 14():944. PubMed ID: 25495526
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
12. A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.
Kong LM; Liao CG; Zhang Y; Xu J; Li Y; Huang W; Zhang Y; Bian H; Chen ZN
Cancer Res; 2014 Jul; 74(14):3764-78. PubMed ID: 24906624
[TBL] [Abstract][Full Text] [Related]
13. The MAP3K13-TRIM25-FBXW7α axis affects c-Myc protein stability and tumor development.
Zhang Q; Li X; Cui K; Liu C; Wu M; Prochownik EV; Li Y
Cell Death Differ; 2020 Feb; 27(2):420-433. PubMed ID: 31186535
[TBL] [Abstract][Full Text] [Related]
14. MiR-4282 inhibits proliferation, invasion and metastasis of human breast cancer by targeting Myc.
Zhao J; Jiang GQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8763-8771. PubMed ID: 30575917
[TBL] [Abstract][Full Text] [Related]
15. SRC Increases
Abdullah C; Korkaya H; Iizuka S; Courtneidge SA
Mol Cell Biol; 2018 Mar; 38(6):. PubMed ID: 29263157
[TBL] [Abstract][Full Text] [Related]
16. C-myc/miR-150/EPG5 axis mediated dysfunction of autophagy promotes development of non-small cell lung cancer.
Li H; Liu J; Cao W; Xiao X; Liang L; Liu-Smith F; Wang W; Liu H; Zhou P; Ouyang R; Yuan Z; Liu J; Ye M; Zhang B
Theranostics; 2019; 9(18):5134-5148. PubMed ID: 31410206
[No Abstract] [Full Text] [Related]
17. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC.
Takahashi Y; Sheridan P; Niida A; Sawada G; Uchi R; Mizuno H; Kurashige J; Sugimachi K; Sasaki S; Shimada Y; Hase K; Kusunoki M; Kudo S; Watanabe M; Yamada K; Sugihara K; Yamamoto H; Suzuki A; Doki Y; Miyano S; Mori M; Mimori K
Ann Oncol; 2015 May; 26(5):935-942. PubMed ID: 25632068
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966
[TBL] [Abstract][Full Text] [Related]
19. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
20. p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA.
Xu LZ; Li SS; Zhou W; Kang ZJ; Zhang QX; Kamran M; Xu J; Liang DP; Wang CL; Hou ZJ; Wan XB; Wang HJ; Lam EW; Zhao ZW; Liu Q
Oncogene; 2017 Jan; 36(3):304-317. PubMed ID: 27345399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
